Instead, we aimed to determine if [99mTc]Tc-anti-TNF-alpha could detect active inflammatory sites, thereby serving as a proof-of-concept for its potential development as a theranostic agent to aid clinicians in identifying and guiding therapeutic strategies in HS patients in future research. Here, TNF is linked to histiocytic sarcoma.